Amino acid insertions at position 35 of HIV-1 protease interfere with virus replication without modifying antiviral drug susceptibility

Antiviral Research

Volumn 69, Issue 3, 2006, Pages 181-185

  Paolucci, Stefania ^a   Baldanti, Fausto ^a   Dossena, Luca ^a   Gerna, Giuseppe ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Drug resistance; HIV 1; Insertion; Protease; Viral replication

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; PROTEINASE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR; VIRUS RNA; ZIDOVUDINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; GENE INSERTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VIRUS MUTATION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN; WILD TYPE;

ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; GENES, VIRAL; HELA CELLS; HIV INFECTIONS; HIV PROTEASE; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS, INSERTIONAL; MUTATION; RNA, VIRAL; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 32644466593     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2005.12.005     Document Type: Article

References (13)

1. E. Domingo, and J.J. Holland RNA virus mutations and fitness for survival Annu. Rev. Microbiol. 51 1997 151 178
2. R.M. Grant, J.O. Kahn, T. Wrin, B. Drews, J. Javier, M. Webb, C.J. Petropolou, and F.M. Hecht HIV-1 with an insertion in protease is drug-susceptible, replication-competent and transmissible Antiviral Ther. 6 Suppl. 1 2001 44
3. Higuchi, R., 1990. Recombinant PCR. In: White, T.J. (Eds.), PCR Protocols. A Guide to Method and Applications. Academic Press Inc., San Diego, CA, pp. 176-183.
4. E.Y. Kim, M.A. Winters, R.M. Kagan, and T.C. Merigan Functional correlates of insertion mutations in the protease gene of human immunodeficiency virus type 1 isolates from patients J. Virol. 75 2001 11227 11233
5. S. Menzo, S. Rusconi, A. Monachetti, M.C. Colombo, M. Violin, P. Bagnarelli, P.E. Varaldo, M. Moroni, M. Galli, C. Balotta, and M. Clementi Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy AIDS 14 2000 1101 1110
6. M. Nijhuis, R. Schuurman, D. de Jong, J. Erickson, E. Gustchina, J. Albert, P. Schipper, S. Gulnik, and C.A. Boucher Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy AIDS 13 1999 2349 2359
7. S. Paolucci, F. Baldanti, G. Campanini, M. Zavattoni, E. Cattaneo, L. Dossena, and G. Gerna Analysis of HIV drug-resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment-naive and HAART patients J. Med. Virol. 65 2001 207 217
8. S. Paolucci, F. Baldanti, G. Maga, R. Cancio, M. Zazzi, M. Zavattoni, A. Chiesa, S. Spadari, and G. Gerna Gln145Met/Leu changes in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nucleoside and nonnucleoside analogs and impair virus replication Antimicrob. Agents Chemother. 48 2004 4611 4617
9. S. Paolucci, F. Baldanti, M. Zavattoni, G. Comolli, N. Labo, S. Menzo, M. Clementi, and G. Gerna Comparison of levels of HIV-1 resistance to protease inhibitors by recombinant versus conventional virus phenotypic assay and two genotypic interpretation procedures in treatment-naive and HAART-experienced HIV-infected patients J. Antimicrob. Chemother. 51 2003 135 139
10. P.L. Sharma, V. Nurpeisov, K. Lee, S. Skaggs, C.A. Di San Filippo, and R.F. Schinazi Replication-dependent 65R→K reversion in human immunodeficiency virus type 1 reverse transcriptase double mutant K65R + L74V Virology 321 2004 222 234
11. V. Simon, N. Padte, D. Murray, J. Vanderhoeven, T. Wrin, N. Parkin, M. Di Mascio, and M. Markowitz Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infection J. Virol. 77 2003 7736 7745
12. M. Sturmer, S. Staszewski, H.W. Doerr, and K. Hertogs A 6-base pair insertion in the protease gene of HIV type 1 detected in a protease inhibitor-naive patient is not associated with indinavir treatment failure AIDS Res. Hum. Retroviruses 19 2003 967 968
13. D. Turner, B. Brenner, J.P. Routy, D. Moisi, Z. Rosberger, M. Roger, and M.A. Wainberg Diminished representation of HIV-1 variants containing select drug resistance-conferring mutations in primary HIV-1 infection J. Acquir. Immune Defic. Syndr. 37 2004 1627 1631